EHABEnhabit, Inc. shows mixed signals. While its fundamental health is stable, recent performance has been negative, and technical indicators suggest a cautious outlook. Thematic positioning is neutral, with no strong industry tailwinds identified.
Enhabit operates in the healthcare services sector, specifically home health and hospice. While healthcare is a stable sector, there are no strong emerging thematic tailwinds or headwinds identified for this specific sub-sector at this time. Growth is expected to be steady rather than explosive.
Enhabit shows a concerning trend of declining profitability and revenue over recent periods. While the balance sheet appears manageable, the negative net income and EPS are significant concerns.
The stock is trading below key moving averages and shows weak momentum across multiple timeframes. RSI and Stochastic indicators suggest selling pressure, with no strong buy signals present.
| Factor | Score |
|---|---|
| Healthcare Services Demand | 65 |
| Regulatory Environment | 40 |
| Digital Health Integration | 35 |
| Competitive Landscape | 50 |
| Economic Sensitivity | 65 |
| Factor | Score |
|---|---|
| Valuation | 60 |
| Profitability | 10 |
| Growth | 25 |
| Balance Sheet Health | 50 |
| Cash Flow | 60 |
| Factor | Score |
|---|---|
| Trend Analysis | 30 |
| Momentum | 20 |
| Volume Confirmation | 30 |
| Support & Resistance | 70 |
| Oscillators | 30 |
Attractive Valuation
The Price-to-Sales (PS) ratio of 0.4 is well below the industry average of 1.5, indicating potential undervaluation relative to revenue.
Strong Debt Coverage
The company has a Debt-to-Equity ratio of 0.46, suggesting a manageable level of debt relative to its equity.
Net Losses
The company has reported net losses for the past few years, with a TTM net income of -$138.4 million, indicating ongoing profitability challenges.
Downtrending Moving Averages
Multiple moving averages, including the 100-day and 200-day Exponential Moving Averages, are trading above the current price, suggesting a bearish trend.
August 2025
7
Next Earnings Date
H: $0.11
A: $0.10
L: $0.09
H: 265.84M
A: 263.39M
L: 260.40M
Enhabit, Inc. provides home health and hospice services in the United States. The company's home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. It also provides hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.
10.25 USD
The 39 analysts offering 1 year price forecasts for EHAB have a max estimate of 12.00 and a min estimate of 9.00.